Turn Therapeutics (TTRX) Income Statement (2024 - 2026)
Income Statement report data from Sep 30, 2024 to Mar 31, 2026 for Turn Therapeutics (TTRX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Sep 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | |
|---|---|---|---|---|
Operating Expenses | ||||
Research And Development | 110K (-31.25%) | 160K (+1500.00%) | 10K (-93.33%) | 150K |
Selling General And Administrative | 1.14M (-34.86%) | 1.75M (+360.53%) | 380K (-26.92%) | 520K |
Operating Expenses | 1.25M (-34.55%) | 1.91M (+402.63%) | 380K (-43.28%) | 670K |
Operating Income | ||||
Operating Income | -1.25M (-34.55%) | -1.91M (+402.63%) | -380.00K (-43.28%) | -670.00K |
Ebit | -1.25M (-34.55%) | -1.91M (+402.63%) | -380.00K (-43.28%) | -670.00K |
EBITDA | -970.00K (-48.95%) | -1.90M (+475.76%) | -330.00K (-50.75%) | -670.00K |
Other Income / Expenses | ||||
Interest Income | 50K (+400.00%) | 10K (0.00%) | 10K (0.00%) | 10K |
Net Interest Income | 50K (+400.00%) | 10K (0.00%) | 10K (0.00%) | 10K |
Other Non Operating Income | 10K | - | 50K (+400.00%) | 10K |
Net Income | ||||
Net Income From Continuing Operations | -970.00K (-48.95%) | -1.90M (+475.76%) | -330.00K (-50.75%) | -670.00K |
Net Income | -970.00K (-48.95%) | -1.90M (+475.76%) | -330.00K (-50.75%) | -670.00K |